Decree: Trump is accountable for “socialist health system in Germany” | EUROtoday
The Americans can be excluded from the pharmaceutical teams as a result of Europeans are masking the remedy costs, stated the US President. A decree ought to now change that. At the identical time, he desires to make drastic financial savings for poorer residents.
US President Donald Trump desires to cut back drug costs within the United States and signed a decree on Monday in Washington to considerably cut back the costs for pharmaceuticals within the USA. At the identical time, he criticized the “Socialist Health System in Germany”, which contributed to the tough state of affairs within the USA.
Trump accuses pharmaceutical firm “to discount their products heavily to gain access to foreign markets”-for instance in Germany and different EU nations. The misplaced revenues then introduced them again in within the USA by way of “extremely high prices”.
His decree ought to treatment this. Trump desires to bind the prices for remedy bought within the USA to the bottom value that’s paid for a similar remedy in different nations. In this manner, price reductions by 59 % had been potential, he promised – in sure instances even from 80 to 90 %. At the identical time, he desires to power the pharmaceutical firms to demand extra for his or her medicines in Europe.
So far, US customers similar to “Trottel” have been besides, Trump was outraged. In explicit, he referred to the Ozempic weight injection from the Danish producer Novo Nordisk. The EU nations are “common” within the drug costs, stated Trump-even “more common than China”.
According to the decree, it’s deliberate that the pharmaceutical firms now cut back their pharmaceutical costs within the United States to the extent in different nations inside 30 days. If this doesn’t occur, the federal government reserves obligatory measures.
It is unclear whether or not the invoice will work: Trump had already tried to cut back remedy costs within the United States throughout his first time period (2017-2021). However, his plans failed as a result of resistance of the pharmaceutical business.
The Association of Researching Pharmaceutical Companies (VFA) in Germany nonetheless named Trumps enactment a “wake-up call” for Europe: a world cap “not only brakes investments in research, but also delays the comprehensive availability of innovative medicinal products,” warned the VFA.
Elsewhere, Trump’s Republicans don’t need to relieve many US residents in well being prices, but additionally to burden them. A draft introduced on Sunday for the federal funds offers for cuts of greater than $ 700 billion for the Medicaid well being program within the coming decade, from which Americans, who’re particularly, profit. According to the congress, not less than 8.6 million US residents might lose their medical insurance by 2034.
The influential democratic MP Frank Pallone stated in order that Trump’s authorities doesn’t lower fats on the perimeters, nevertheless it was “except for the bones”. The deliberate cuts at Medicaid are a part of a complete funds bundle. This is meant to counter-financed the tax reliefs supplied by Trump within the prospect and likewise expanded the US border safety.
AFP/FHS
https://www.welt.de/politik/ausland/article256106778/Erlass-Trump-gibt-sozialistischem-Gesundheitssystem-in-Deutschland-Schuld-an-hohen-Arzneipreisen-in-USA.html